Наиболее широко в качестве иммунодепрессантов используется Азатиоприн. 30 Таким образом, существующие в настоящее время иммунодепрессанты не.


Чтобы посмотреть этот PDF файл с форматированием и разметкой, скачайте его и откройте на своем компьютере.
!"##$%#&'()*+*!',$(
)*+*!'-./'(#-012'
3"$/4*--*&40'-./"%#"2#45*//"#4$
(51)
63&
A61K31/30
(2006.01)
A61K31/4178
(2006.01)
A61K31/473
(2006.01)
A61P37/06
(2006.01)
(19)
(11)
2448696
(13)
(12)
"3$#'/$*$7"2!*4*/$(&3'4*/40
(21)(22)
789:;8
2011100489/15, 11.01.2011
(24)
+88=8&#x-36.;h-2;V.6;&#x=-8.;h-0;&#x.400;[email protected]&#x-12.;⨀[email protected];8DBEA:F9G8B=8
11.01.2011
[email protected]
(22)
[email protected]&#x-208;&#x-240;&#[email protected];&#x.2D8;.2;FI89:;F
11.01.2011
(45)
"GJK?F;@:[email protected]
27.04.2012
2L?
(56)
#[email protected];[email protected];[email protected]:
[email protected]:8==HP:@Ȳ.; [email protected]
[email protected];B
RU 2190616
1, 10.10.2002. RU 2089555
1, 10.09.1997. CN 101735217
, 15.12.2009.
2371811
2, 12.05.2005.
1826197
29.08.2007.
'DCBAD?9GBCBGFA;F
634050,
[email protected];
[email protected];@:A;FEC8;
, 2,
#FKW60
@DB?$#F5
7JK8CB:@E
(72)
':@C
[email protected]=F;@:[email protected]&#x=F;-;&#[email protected];&#x.8:-;ɨ.;…-4;&#x.2?-;x-0;&#x.4D6;&#x.2F-;NF;&#x-10C;&#x-253;&#x.461;&#x.5F-;P8;-10;&#x?17.;&#[email protected];.6:;:F
(RU)
28E;@:'?B;A8=DC/F;@?8B:F�
(RU)
3BCB:@�IF;@:[email protected]:=8
(RU)
(73)
[email protected]@K?8D8B?T
[email protected]=F;@:[email protected]&#x=F;-;&#[email protected];&#x.8:-;ɨ.;…-4;&#x.2?-;x-0;&#x.4D6;&#x.2F-;NF;&#x-10C;&#x-253;&#x.461;&#x.5F-;P8;-10;&#x?17.;&#[email protected];.6:;:F
(RU)
28E;@:'?B;A8=DC/F;@?8B:F�
(RU)
3BCB:@�IF;@:[email protected]:=8
(RU)
(54)
#!*+#45"
"2-'+'pq**$660/"+*3!*##$5/"%'&4$5/"#4.p
(57)
!BSBC8
[email protected][email protected][email protected];S8CN8;@[email protected]
NBDFOF=BF;8A8BA9GCFNB=B=F9
[email protected]?
-(1,10)-
[email protected]?F=8NBDF
(II)
[email protected]:;8�BA:BACBDA:8
@[email protected]
[email protected]:[email protected][email protected]:[email protected]
8;F:[email protected]
8K?
.: 1
RU2448696C1
RUSSIAN FEDERATION
FEDERAL SERVICE
FOR INTELLECTUAL PROPERTY
(51)Int. Cl.
A61K31/30
(2006.01)
A61K31/4178
(2006.01)
A61K31/473
(2006.01)
A61P37/06
(2006.01)
(19)
(11)
2448696
(13)
(12)
ABSTRACT OF INVENTION
(21)(22)Application:
2011100489/15, 11.01.2011
(24)Effective date for property rights:
11.01.2011
Priority:
(22)Date of filing:
11.01.2011
(45)Date of publication:
27.04.2012Bull.12
Mail address:
634050, g.Tomsk, Moskovskij trakt, 2, SibGMU,
otdel IS i V, N.G. Zubarevoj
(72)Inventor(s):
Plotnikov Vladimir
Mikhajlovich (RU)
Bajkov Aleksandr Nikolaevich (RU)
Perevozchikova Tat'ja
na Vladimirovna (RU)
(73)Proprietor(s):
Plotnikov Vladimir
Mikhajlovich (RU)
Bajkov Aleksandr Nikolaevich (RU)
Perevozchikova Tat'ja
na Vladimirovna (RU)
(54)
IMMUNOSUPPRESSANT
(57)Abstract:
FIELD: medicine, pharmaceutics.
SUBSTANCE: invention
refers to pharmacology
and medicine, and con
cerns using copper (II)
bisimidazole-(1,10)-phenath
roline dichloride as an
agent showing high immunosuppressive activity.
EFFECT: preparing the agent showing high
immunosuppressive activity.
1 dwg, 1 tbl
.: 2
RU2448696C1
RU2448696C1
[email protected][email protected][email protected];S8CN8;@[email protected]
;@@[email protected][email protected][email protected]:
[email protected]:[email protected]:=JL8;F:[email protected]
[email protected]@[email protected]:[email protected]:
NBDFOF=B
@=;@[email protected][email protected][email protected][email protected]
$I:BA=HACBDA:8
@[email protected]:[email protected];F:[email protected]
GCBDA8:?9LXFBC8I.98;&#x:?91;.9L;&#x-13.;XF5;&#x.9B-;ɦ.;鰐&#x.58-;.9;&#xI18.;?F0;?F=HBS8CN8;@[email protected].98;&#x:?91;.9L;&#x-13.;XF5;&#x.9B-;ɦ.;鰐&#x.58-;.9;&#xI18.;?F0;FBA;FBRCJGGH
R?L;@;@CF;@[email protected]
[email protected]@;A&#[email protected];A1;.6F;FBA;FBGCBG8C8H
=B;@@[email protected];F
[email protected][email protected]
/[email protected][email protected];@:;8�BA:[email protected][email protected]:[email protected]?TIJBA9'[email protected]=
FNJC8=
[email protected]�BA;@EACJ;JCB
[email protected][email protected][email protected]&#x-23.;<-8;&#[email protected];ʛ=;&#x-36.;O-1;.1L;&#x-288;&#x.1F-;ʈ.;K-8;&#x.5F-;#.3;&#[email protected];?-2;&#[email protected];&#x-18.;R-2;.6F;&#x-13.;ကBA;@NJDBEA:[email protected];
NBC;[email protected]=J
[email protected]:[email protected]:[email protected][email protected]:[email protected]@G?8IFBE
[email protected][email protected];8=F
A=FVB=FBN;@?�FBA:84
[email protected]@:
[email protected][email protected]=B8B
SJ=;OFL;@[email protected]@[email protected]
[email protected]:[email protected][email protected]@:
:HIH:8B
?BE;@GB=FL
3CFGCFBNB:HIH:[email protected][email protected]
[email protected]=B=FF
[email protected]:[email protected];AF&#[email protected]; A-;.5F;&#x-10.;оBA;FERBG8F
8??BCR�FBA;FBCB8;OFF
3C8;F.9F;.1;BA;F=B
C8A:@CFN::@DB
[email protected]:?B=F9CB8;OFF;8=B:@[email protected]:[email protected]
GBCBA8D;BG�@B;
@[email protected]:F;8=BE
88;VBGCF?Bh-1;�.8;;V-9;&#x.2B-;Ɇ.;G-1;.3C;.6;-25; .5?;&#x-1.2;¸.9;B=FF=B;@@[email protected]==HP
[email protected]?B:8=F9P
$I:BAB=OF;[email protected]@CF=
[email protected][email protected]@DH
[email protected];
)[1].
3CBG8C8
:[email protected]:[email protected][email protected]:=HNACBDA:@NGCFNB=9BNHED?9JNB=TUB=F9
CB8;[email protected]@[email protected][email protected][email protected];BG-26;.4J;&#x-266;&#x.4K0;&#[email protected];?-1;&#x.5T-; .9=;&#x-17.;H13;&#x.9P-;ɶ.;G-7;&#x.4C0;-25; .88;&#x-0.9;&#x?8.7;&#x?8.7;&#[email protected];&#x.2R-;.1;ଘ.;=-1;.6=;&#x-7.4;&#[email protected];Y.8;&#xGBCB;.6A;.68;&#x-0.9; B-;ɖ.; G-7;&#[email protected];@;F
ABCDO8
?BR;FPFDC
@[email protected]:
88;VB;@[email protected]@[email protected]
3�@[email protected][email protected]:FBGCBG8C88
@[email protected]:[email protected]:[email protected];@[email protected]
[email protected]@;&#x-23.;&#[email protected];-;.6;꼀[email protected]
$I:[email protected]?
'[email protected]@[email protected]?
GCBDA8:?9LXFEANBAT
[email protected]@[email protected][email protected][email protected]=88;8?TOF9
(70%)
FR?L;@=88;8?TOF9
(30%),
[email protected]
33,5%
[email protected][email protected]
[1].
3CFNB=9L::FDBAJAGB=IFF
=BC8A:@CFN::@DB
�@[email protected][email protected]=HND?9
:=JCF:[email protected]@[email protected][email protected]:8=F9
[email protected]?TIJL:@[email protected]:[email protected]?B&#x-268;&#x.7:-;&#[email protected];&#x-9A2;�=-1;&#[email protected];.5;&#x:-9.;&#[email protected]; N-2;b.5;&#xG-6.;ˏ-;ɘ.;?B2;�[email protected]:
48;[email protected]@N
AJXBA:JLXFB:[email protected]:[email protected]=H=B
@[email protected]&#[email protected];[email protected][email protected][email protected]:[email protected][email protected]:8=FB
[email protected]@:@VD8BA9:[email protected].9A;.89;&#x-258;&#x.7:H;ఐ.;X-1;�.9V;¸.8;&#x=-7.;=-1;.4H;.1;&#xN-18;&#x.5F-;ə.;&#[email protected];&#x-10K;.5;&#[email protected];@=HNF9:?B=F9NF
"[email protected]@;8IH:8T
JR=B8LXBB:?F9=FB=8;[email protected]:B:@CB=FBF:HIH:8T?BE;@GB=FLF8=BNFL
:[email protected]=H
8;F:8OF9:@CF&#[email protected];Œ-6;&#x.7F9;&#x.200;[email protected]=SB;OFF
C8I:FFBABGFOBNFF
@;AF&#[email protected];&#x.3;A;-12;&#x.600;BA;@B:@IDBEA:FB=8
[email protected]�;FFGB�B=T/[email protected]?BBK?FI;FN;[email protected]:[email protected][email protected]
'[email protected][email protected]=
'[email protected]=FDC
.).
[email protected];JCB
[email protected]
R?L;@[email protected]@
CF][email protected]=
[email protected][email protected]
2,3,4,6-
BC88OB8
[1].
48;[email protected]@N
AJXBA:JLXFB:[email protected]:[email protected]=H=B
@[email protected]&#[email protected];[email protected][email protected][email protected]:[email protected][email protected]:8=FB
[email protected]@:@VD8BA9:[email protected].9A;.89;&#x-258;&#x.7:H;ఐ.;X-1;�.9V;¸.8;&#x=-7.;=-1;.4H;.1;&#xN-18;&#x.5F-;ə.;&#[email protected];&#x-10K;.5;&#[email protected];@=HNF9:?B=F9NF
"[email protected]@;8IH:8T
JR=B8LXBB:?F9=FB=8;[email protected]:B:@CB=FBF:HIH:8T?BE;@GB=FLF8=BNFL
:[email protected]=H
8;F:8OF9:@CF&#[email protected];Œ-6;&#x.7F9;&#x.200;[email protected]=SB;OFF
C8I:FFBABGFOBNFF
@;AF&#[email protected];&#x.3;A;-12;&#x.600;BA;@B:@IDBEA:FB=8
[email protected]�;FFG�BB=T
48;VB8CAB=8?
:�[email protected]
@B&#x-19.;笓&#x.800;BA:B==HP?B;8CA:B==HPACBDA:
;@@[email protected][email protected];[email protected]=8I=8.8T;ਖ.;™-2;@.4;&#xG-9.;&#[email protected];F.9;&#xJ7.4;&#x;87.;I16;&#x.387;&#x.4==;&#x-9.3;&#[email protected];N-0;&#x.2J-;ɘ.;=11;&#x.18I;.3;&#x=87.;оB=FL
[email protected]@&#[email protected];.7;B=
/@:89BP=ଠ.;P-9;&#x.2=-;.5F;FBA;89I8ଠ.;P-9;&#x.2=-;.5F;D88
C8AUFCB=FB8CAB=8?8?B;8CA:B==HPACBDA:
@[email protected]:[email protected];F:[email protected]
[email protected]&#[email protected];[email protected][email protected][email protected]
DBEA:F9FD8LXFP=8FNB=TUBB&#x-10.;:13;&#x.6F9;&#x-244;&#x.4F-;ɕ.;ד.;ˆL-; .7X;.1F;&#x-0.2;&#xP-26;.1=;.18;&#x-6.8;༐N;଒.; =T-;.6U;଒.;›-2;R.6;[email protected]@[email protected]=B=FEGCFGCFNB=B=FF
[email protected]:[email protected].98;&#x-9.9;&#x:0.3;&#x?9.9; -0.;=-6;&#x.2=-;&#[email protected];.2E;&#x-258;&#x.6I9;&#x.28D;.9;-9.;退F:;8.98;&#x-9.9;&#x:0.3;&#x?9.9; -0.;=-6;&#x.2=-;&#[email protected];.2E;&#x-258;&#x.6I9;&#x.28D;.9;-9.;退BA:BACBDA:8
@[email protected]
[email protected]:[email protected];F:[email protected]
[email protected][email protected]?
-(1,10)-
[email protected]?F=
NBDF
(II)
[email protected]
[email protected]?
-(1,10)-
[email protected]?F=NBDF
(II)
[email protected]@DBCVF:@:=JCB==BEASBCBD:B
.: 3
15
20
25
30
35
40
45
50
RU2448696C1
[email protected]?B;[email protected]?8
(Im)
[email protected]
A:[email protected]?B;J?J
1,10-
[email protected]?F=8
(Phen)
:@:=BU=BE
[email protected]:BXBA:@[email protected]?J&#x-23.; :@-;ɴ.;G-1;&#[email protected];&#x-9.2;&#x?-10;&#x.7J-;.1;8LGJBN:[email protected]:F9
CuCl
[email protected]:@NC8A:@CBA
1,10-
[email protected][email protected]@[email protected]@[email protected]@@[email protected]=FF
;@[email protected][email protected]:
[email protected]@[email protected]:@CFN::@DB
[email protected]:BDB=FF];AGBCFNB=8?T=HP
[email protected]:8=FEJGCBG8C88KH?8:H9:?B=88=FK8;[email protected]:@@[email protected]?B:89
8;F:[email protected]
[2].
/@:@BA:@EA:@GCBG8C88
=8?F�[email protected]:[email protected];F:[email protected][email protected]
:H9:[email protected]@[email protected][email protected][email protected]:8=FF
[email protected]:[email protected]@:8=FBDBEA:F9
[email protected];@NGBB==HB;?B;[email protected][email protected]@:&#x;-15;&#x.1F-;ɨ.;M-9;&#[email protected]=;&#x-26.;&#[email protected];.8;&#[email protected]:-2;±[email protected]:B;8:CB8;[email protected]
[email protected][email protected]@:
!24-
[email protected]:[email protected][email protected]
)W'
[email protected]?BDBEA:[email protected]::[email protected]=B;@=OB=C8OFE
1-0,001
"OB=;8:?F9=F9
[email protected]?FSBC8F:=JL8;F:[email protected][email protected]@::[email protected][email protected]
[email protected]:[email protected])W'[email protected]:BDB=8:[email protected]@:BA:[email protected]&#[email protected];.6D;.3;-2.;退BA;FNF
CB;@NB=D8OF9NF)8CN;@NFB867!)
[email protected]@AFS8CN8;@[email protected].3;-25;.2S;&#x-10.;᠖&#x.9C7;&#x.6N8;.7;;.3;&#[email protected];?26;&#[email protected];.6R;RFBA;@[email protected];@NFB8
1999,
1),
88;VB:[email protected]@&#[email protected];&#x;AF0;@;[email protected]@@;C8A;[email protected]:HN
AF=FN
[email protected]:=898;F:[email protected]:?B=8=8RC8SF;BSFR
.1,
FI;@@[email protected]@
:[email protected]
�@I89:[email protected]:@:FIJ&#x:-9.;&#[email protected];S.5;&#x:-26;.7F;&#xI19.; J-9;&#x.400;B==HP;@[email protected];8IH:8BF=RFKFCJLXBB
DBEA:[email protected]=8==JL8;F:[email protected][email protected]@::[email protected]=B
1-0,1
40-100%
[email protected]:?998;@:[email protected][email protected][email protected];@[email protected]?9
[email protected]@[email protected]
:[email protected]
�@I89:[email protected]
ACBDA:@@;8IH:8BJR=B8LXBBDBEA:[email protected]:8==JL)W'[email protected]?FSBC8F:=JL
8;F:[email protected][email protected]@:
48;[email protected]:[email protected]@[email protected]:[email protected]@&#x-21.;&#[email protected];&#x.6;A;;AFBA;@[email protected]:F9
I89:[email protected]@ACBDA:[email protected]&#xH-26;�.30;[email protected]:B;8:;@=OB=C8OFF
1-0,1
=8K?LDB=FE
:CBIJ?T8B;@@[email protected]:[email protected]
�@ACBDA:@@;8IH:8B
[email protected]@;A&#[email protected];A1;.1F;FBA;@BDBEA:[email protected];@NGBB==HB;?B;F
.1).
5?FBC8JC=HPFA&#[email protected];@=F;[email protected]:JLA:[email protected]=B=FFI89:[email protected]@
ACBDA:8:[email protected][email protected]&#x-13.;:-9;&#x.78-;ɵ.;:-2;ٟ-;.3;&#xN-7.;N-2;.5J;&#x=-26;&#[email protected]?;&#x-10.;&#[email protected];%.9;FBA;@EGC8;F;B
:�[email protected]@:=9BP=F;F
[email protected]:=HBA:@EA:[email protected]@NB==BFI:BA=H
�@[email protected]:BCVD8B
[email protected]@:BA:FB;CFBCFL[[email protected]:FI=8\
[email protected]�B:[email protected]=8?F&#xT-29;=-5;&#x.68-;.5;&#x?F-1;.90;[email protected]=RFKFCJLXBE
8;F:[email protected]@I:@[email protected]:@[email protected]@@:BA:[email protected];CFBCFL[[email protected]?TA;FE
[email protected]:B=T\
48;[email protected]@N
[email protected]:@B:H9:[email protected]:@EA:@[email protected]?
-(1,10)-
[email protected]?F=
NBDF
(II)
[email protected]@I:@?F=8EFBNJGCFNB=B=FB:;8.6F;&#x-269;&#x.1B1; .7N;&#x-7.6;&#xJ-26;.5G;&#x-6.5;೶.;N-7;&#x.6B9;&#x.5=-;.5B;&#x-0.7;&#x=FB-;ɖ:;&#x-255;&#x.3;-;.68;�BA:BACBDA:8
@[email protected]
[email protected]:[email protected];F:[email protected]
[email protected][email protected]@;AF&#[email protected];&#x-9.2;&#x;4.7;©.6;ö.7;BA;@[email protected]:[email protected]?
-(1,10)-
[email protected]?F=
NBDF
(II)
[email protected][email protected]:BDB=H:8K?FOB
)FR
.1.
[email protected]:8=FB:?F9=F9-#
(Cu Phen Im 2)
[email protected];@NGBB==HB;?B;F
[email protected][email protected][email protected]:B;8:CB8;OFF!24-
[email protected][email protected][email protected]@:
;@[email protected]?TKBIGCBG8C88
[email protected][email protected]@:[email protected]?B:@IDBEA:[email protected]?LF=F=8
)W'
;@[email protected]?TKBIGCBG8C88
I89:[email protected]:@
[email protected]&#[email protected];=F;[email protected]
68U;@:A;FE
-B;8CA:B==HBACBDA:8
BFID
/@:89:@?=8
, 2007,
.743-
746.
38B=!)M
2190616,
@GJK?
48K?FO8
[email protected][email protected]@K=HP;[email protected];&#[email protected];&#x;-24;.30;BCBI
[email protected]:F=;JK8OFF
(%)
GCF:@IDBEA:FFACBDA:8:[email protected]
0,1-1
.: 4
RU2448696C1
2BI:@IDBEA:F9ACBDA:8#I89:?9BNHNACBDA:@N
0,11
94455
)@[email protected]=F9
[email protected]?
-(1,10)-
[email protected]?F=NBDF
(II)
[email protected]@CNJ?Ha
:;8�BA:BACBDA:8
[email protected]:[email protected][email protected]:=JL8;F:[email protected]
.: 5
15
20
25
30
35
40
45
50
RU2448696C1
.: 6

Приложенные файлы

  • pdf 14919417
    Размер файла: 169 kB Загрузок: 0

Добавить комментарий